Changes in dopamine and acetylcholine in striatum of the awake rat after chronic treatment with a dopamine uptake blocker

Brain Research Bulletin

Volumn 68, Issue 6, 2006, Pages 448-452

  Hernandez L F ^a   Segovia, G ^a   Mora, F ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Acetylcholine; Dopamine; Dopamine uptake inhibitor; Microdialysis; Striatum

Indexed keywords

ACETYLCHOLINE; DOPAMINE; DOPAMINE UPTAKE INHIBITOR; NOMIFENSINE;

ACETYLCHOLINE BRAIN LEVEL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DRUG EFFECT; LONG TERM CARE; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETYLCHOLINE; ANIMALS; CORPUS STRIATUM; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DRUG ADMINISTRATION SCHEDULE; EXTRACELLULAR FLUID; MALE; MICRODIALYSIS; NOMIFENSINE; RATS; RATS, WISTAR; SYNAPTIC TRANSMISSION; TIME FACTORS; WAKEFULNESS;

EID: 31744444530     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2005.10.003     Document Type: Article

References (38)

1. E.D. Abercrombie, and P. DeBoer Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism J. Neurosci. 17 1997 8498 8505
2. E. Acquas, and G. Di Chiara Local application of SCH39166 reversibly and dose-dependently decreases acetylcholine release in the rat striatum Eur. J. Pharmacol. 383 1999 275 279
3. M.E. Alburges, D.J. Crouch, D.K. Andrenyak, and J.K. Wamsley Lack of long-term changes in cocaine and monoamine concentrations in rat CNS following chronic administration of cocaine Neurochem. Int. 28 1996 51 57
4. M.E. Alburges, N. Narang, and J.K. Wamsley Alterations in the dopaminergic receptor system after chronic administration of cocaine Synapse 14 1993 314 323
5. A.A. Alcantara, V. Chen, B.E. Herring, J.M. Mendenhall, and M.L. Berlanga Localization of dopamine D2 receptors on cholinergic interneurons of the dorsal striatum and nucleus accumbens of the rat Brain Res. 986 2003 22 29
6. S.P. Butcher, J. Liptrot, and G.W. Aburthnott Characterisation of methylphenidate and nomifensine induced dopamine release in rat striatum using in vivo brain microdialysis Neurosci. Lett. 122 1991 245 248
7. H.T. Chang Dopamine-acetylcholine interaction in the rat striatum: a dual-labeling immunocytochemical study Brain Res. Bull. 21 1988 295 304
8. S.C. Cheetham, C.J. Kettle, K.F. Martin, and D.J. Heal D1 receptor binding in rat striatum: modification by various D1 and D2 antagonists, but not by sibutramine hydrochloride, antidepressants or treatments which enhance central dopaminergic function J. Neural Transm. Gen. Sect. 102 1995 35 46
9. S. Consolo, M. Sieklucka, F. Fiorentini, G.L. Forloni, and H. Ladinsky Frontal decortication and adaptive changes in striatal cholinergic neurons in the rat Brain Res. 363 1986 128 134
10. G. Damsma, G.S. Robertson, C.H. Tham, and H.C. Fibiger Dopaminergic regulation of striatal acetylcholine release: importance of D1 and N-Methyl-d-Aspartate receptors J. Pharmacol. Exp. Ther. 259 1991 1064 1072
11. J. de Belleroche, J. Coutinho-Netto, and H.F. Bradford Dopamine inhibition of the release of endogenous acetylcholine from corpus striatum and cerebral cortex in tissue slices and synaptosomes: a presynaptic response? J. Neurochem. 39 1982 217 222
12. P. DeBoer, and E.D. Abercrombie Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes J. Pharmacol. Exp. Ther. 277 1996 775 783
13. P. DeBoer, G. Damsma, H.C. Fibiger, W. Timmerman, J.B. De Vries, and B.H.C. Westerink Dopaminergic-cholinergic interactions in the striatum: the critical significance of calcium concentrations in brain microdialysis Naunyn-Schmiedeberg's Arch. Pharmacol. 342 1990 528 534
14. S.M. Florin, R. Kuczenski, and D.S. Segal Amphetamine-induced changes in behavior and caudate extracelluar acetylcholine Brain Res. 581 1992 53 58
15. A.N. Gifford, and K.M. Johnson Effect of chronic cocaine treatment on D2 receptors regulating the release of dopamine and acetylcholine in the nucleus accumbens and striatum Pharmacol. Biochem. Behav. 41 1992 841 846
16. J.A. Girault, and P. Greengard The neurobiology of dopamine signaling Arch. Neurol. 61 2004 641 644
17. A.M. Graybiel, E.C. Hirsch, and Y. Agid The nigrostriatal system in Parkinson's diseases Adv. Neurol. 53 1990 17 29
18. R. Guennoun, and B. Bloch Ontogeny of D1 and DARPP-32 gene expression in the rat striatum: an in situ hybridization study Brain Res. Mol. Brain Res. 12 1992 131 139
19. E.C. Hennings, J.P. Kiss, K. De Oliveira, P.T. Toth, and E.S. Vizi Nicotinic acetylcholine receptor antagonistic activity of monoamine uptake blockers in rat hippocampal slices J. Neurochem. 73 1999 1043 1050
20. L.F. Hernández, G. Segovia, and F. Mora Effects of activation of NMDA and AMPA glutamate receptors on the extracellular concentrations of dopamine, acetylcholine and GABA in striatum of the awake rat: a microdialysis study Neurochem. Res. 28 2003 1819 1827
21. Y. Ikarashi, A. Takahashi, H. Ishimaru, T. Arai, and Y. Maruyama Regulation of dopamine D1 and D2 receptors on striatal acetylcholine release in rats Brain Res. Bull. 43 1997 107 115
22. J.L. Kinney Nomifensine maleate: a new second-generation antidepressant Clin. Pharm. 4 1985 625 636
23. J.R.F. Konig, and R.A. Klippel The Rat Brain 1967 R.E. Krieger Publishing Co. New York
24. Y. Kubota, S. Inagaki, S. Shimada, S. Kito, F. Eckenstein, and M. Tohyama Neostriatal cholinergic neurons receive direct synaptic inputs from dopaminergic axons Brain Res. 413 1987 179 184
25. R. Kuczenski, and D.S. Segal Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine J. Pharmacol. Exp. Ther. 262 1992 1085 1094
26. M.J. Kuhar, M.C. Ritz, and J.W. Boja The dopamine hypothesis of the reinforcing properties of cocaine Trends Neurosci. 14 1991 299 302
27. N.S. Kula, and R.J. Baldessarini Lack of increase in dopamine transporter binding or function in rat brain tissue after treatment with blockers of neuronal uptake dopamine Neuropharmacology 30 1991 89 92
28. I. Lamensdorf, S. Porat, R. Simantov, and J.P. Finberg Effect of low-dose treatment with selegiline on dopamine transporter (DAT) expression and amphetamine-induced dopamine release in vivo Br. J. Pharmacol. 126 1999 997 1002
29. T. Lee, and S.W. Tang Reduced presynaptic dopamine receptor density after chronic antidepressant treatment in rats Psychiatry Res. 7 1982 111 119
30. J. Lehmann, and Z. Langer The striatal cholinergic interneuron: synaptic target of dopaminergic terminals? Neuroscience 10 1983 1105 1120
31. K.F. Martin, I. Phillips, S.C. Cheetham, and D.J. Heal Dopamine D2 receptors: a potential pharmacological target for nomifensine and tranylcypromine but not other antidepressant treatments Pharmacol. Biochem. Behav. 51 1995 565 569
32. G. Segovia, A. Del Arco, and F. Mora Effects of aging on the interaction between glutamate, dopamine and GABA in striatum and nucleus accumbens of the awake rat J. Neurochem. 73 1999 2063 2072
33. W.G. Snedecor, and G.W. Cochran Statistical Methods 1989 Iowa State Press Ames, IA
34. T.D. Steele, D.B. Hodges Jr., T.R. Levesque, and K.W. Locke D1 agonist dihydrexidine releases acetylcholine and improves cognitive performance in rats Pharmacol. Biochem. Behav. 58 1997 477 483
35. J.C. Stoof, B. Drukarch, P. De Boer, and B.H. Westerink In vitro and in vivo acetylcholine release from rat striatum as a functional paradigm of signal transduction via a D2-dopamine receptor Neurochem. Int. 20 Suppl. 1992 205S
36. J.R. Wamsley, and M.E. Alburges Cocaine causes a time dependent and dose dependent increase in D1 receptors and dopamine transporters Proc. West Pharmacol. Soc. 36 1993 277 282
37. N.J. Woolf, and L.L. Butcher Cholinergic systems in the rat brain: III. Projections from the pontomesencephalic tegmentum to the thalamus, tectum, basal ganglia, and basal forebrain Brain Res. Bull. 16 1986 637
38. J. Yamada, Y. Sugimoto, and S. Yamada Involvement of dopamine receptors in the anti-immobility effects of dopamine re-uptake inhibitors in the forced swimming test Eur. J. Pharmacol. 504 2004 207 211